Memantine, acetylcholinesterase inhibitors, and quality-of-care outcomes among patients with cognitive impairment: an emulated trial design.

Ferguson EL, Wang J, White JS, Possin K, Chodos A, Xia F, Raphael E, Smith AK, Glymour MM

Open source

DOI
10.1002/trc2.70306
Published
2026 Jul-Sep
Container
Alzheimer's & dementia (New York, N. Y.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/trc2.70306,
  title = {Memantine, acetylcholinesterase inhibitors, and quality-of-care outcomes among patients with cognitive impairment: an emulated trial design.},
  author = {Ferguson EL and Wang J and White JS and Possin K and Chodos A and Xia F and Raphael E and Smith AK and Glymour MM},
  year = {2026},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  doi = {10.1002/trc2.70306},
  url = {https://doi.org/10.1002/trc2.70306}
}

RIS

TY  - JOUR
TI  - Memantine, acetylcholinesterase inhibitors, and quality-of-care outcomes among patients with cognitive impairment: an emulated trial design.
AU  - Ferguson EL
AU  - Wang J
AU  - White JS
AU  - Possin K
AU  - Chodos A
AU  - Xia F
AU  - Raphael E
AU  - Smith AK
AU  - Glymour MM
PY  - 2026
JO  - Alzheimer's & dementia (New York, N. Y.)
DO  - 10.1002/trc2.70306
UR  - https://doi.org/10.1002/trc2.70306
ER  - 

APA

EL, F., J, W., JS, W., K, P., A, C., F, X., E, R., AK, S., & MM, G. (2026). Memantine, acetylcholinesterase inhibitors, and quality-of-care outcomes among patients with cognitive impairment: an emulated trial design.. Alzheimer's & dementia (New York, N. Y.). https://doi.org/10.1002/trc2.70306

Source records